Supernus Pharmaceuticals Inc
(NAS:SUPN)
$
48.21
+1.15 (+2.44%)
Market Cap: 2.80 Bil
Enterprise Value: 2.47 Bil
PE Ratio: 0
PB Ratio: 2.71
GF Score: 74/100 Supernus Pharmaceuticals Inc (SUPN) Transcripts
- 1